DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Okines AF, Ashley SE, Cunningham D et al.
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trial.
J Clin Oncol 2010;
28: 3945-3950
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.